0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Haematology

Buy Now

Optimal Circulation - Cells Contribution to Arterial Pressure (Hardcover) Loot Price: R5,754
Discovery Miles 57 540
You Save: R469 (8%)
Optimal Circulation - Cells Contribution to Arterial Pressure (Hardcover): Rafik D Grygoryan

Optimal Circulation - Cells Contribution to Arterial Pressure (Hardcover)

Rafik D Grygoryan

 (sign in to rate)
List price R6,223 Loot Price R5,754 Discovery Miles 57 540 | Repayment Terms: R539 pm x 12* You Save R469 (8%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Prevailing physiological concepts (PPC) of blood circulation consider the cardiovascular system (CVS) an autonomous system that has its own goal and mechanisms for achieving it. Physiologists agreed that complex neural and humoral controllers of a mean arterial pressure (MAP) indirectly alter the blood flows for satisfying cellular needs. However, PPCs are incapable of explaining the causes of long-term shifts of an MAPs rest level. In particular, this affects current understanding and cure technologies of arterial hypertension (AH). Considering AH as a disease, physicians seek a cure that effectively decreases the elevated pressure. This gave rise to the palliative cure softening of AH symptoms without an understanding of AHs primary causes. But this strategy, working until the patient intakes antihypertensive drugs, often leads to AHs further development, and in extreme cases current antihypertensive drugs are helpless. These limitations of PPC are forced to seek a circulations extended physiological theory (EPT), explaining the mechanisms of both normal and altered MAPs. In the EPT presented in the book, CVS is considered a constituent part of a more complex functional super-system (FSS) that appeared in a multi-cellular animal organism during the co-evolution of specialized cells. The general goal of the FSS is to provide optimal physiochemical and energy states of the cell cytoplasm. To achieve this goal under a stochastic total and local variations of cells activity, FSS should control: i) The cardiac output; ii) the regional and local blood flows; and iii) the chemical composition of both arterial and venous blood. Under chronic energy shortage, FSS should also provide an adequate increasing of ATP-synthesis in mitochondria of stagnated cells. So, under the ineffectiveness of current mitochondria, FSS must enrich the arterial blood by chemicals providing the biogenesis of mitochondria. However, neither the energy providers nor the providers of blood chemistry are properly involved in PC of the blood circulation. The EPT for the first time integrates the hemodynamic and metabolic aspects of cell life at the organism scale. It is proved that the CVS activity is inversely associated with the activity mechanisms controlling the rates of both pulmonary ventilation and erythropoiesis. Under significant and chronic energy deficiency, the cells activate additional FSS mechanisms, materially supporting the biogenesis of mitochondria. The activity of FSS mechanisms forming the chemical composition of arterial and venous blood is in reciprocal relationships with the function of CVS. So, the EPT associates the function of CVS with energy and metabolic problems in cells. The EPT concerns both traditional and additional determinants of the MAP level. It is proved that stochastic combinations of these determinants force the MAP level to float. In particular, both the mitochondrial insufficiency and the chemical contamination of cytoplasm are capable of causing AH. The normal arterial pressure is always individual. Before correcting the altered arterial pressure, a complex medical examination for ascertaining the mitochondrial function, the status of the FSS mechanisms is recommended. The diagnosis of AH should be reoriented for detecting cellular abnormalities. The therapy of AH should be targeted at finding strategies for the optimizing the entire FSS function.

General

Imprint: nova science publishers
Country of origin: United States
Release date: October 2017
Authors: Rafik D Grygoryan
Dimensions: 260 x 180 x 25mm (L x W x T)
Format: Hardcover
Pages: 355
ISBN-13: 978-1-5361-2295-4
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Books > Medicine > Clinical & internal medicine > Haematology
Promotions
LSN: 1-5361-2295-5
Barcode: 9781536122954

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Neuroendocrine Tumors, An Issue of…
Jennifer Chan, Matthew Kulke Hardcover R1,744 Discovery Miles 17 440
Blood Banking and Transfusion Medicine…
Christopher D. Hillyer, Leslie E. Silberstein, … Hardcover R8,496 R4,552 Discovery Miles 45 520
Clinical Pathology of the Blood; A…
James Ewing Paperback R681 Discovery Miles 6 810
Anticoagulation - Current Perspectives
Xingshun Qi, Xiaozhong Guo Hardcover R3,404 Discovery Miles 34 040
Nanotechnology for Hematology, Blood…
Adil Denizli, Tuan Anh Nguyen, … Paperback R4,710 Discovery Miles 47 100
Cheto - When live gives you lemons, make…
Tim Foster Hardcover R588 Discovery Miles 5 880
Beta Thalassemia
Marwa Zakaria, Tamer Hassan Hardcover R3,398 Discovery Miles 33 980
Advanced Hematology in Integrated…
Anika Niambi Al-Shura Paperback R3,337 Discovery Miles 33 370
Antiphospholipid Syndrome - Recent…
Polona Zigon Hardcover R3,406 Discovery Miles 34 060
Highlights on Hemodynamics
Theodoros Aslanidis Hardcover R2,815 Discovery Miles 28 150
Hematology - Pathophysiology, Diagnosis…
Pier Luigi Zinzani, Sante Tura, … Hardcover R1,992 Discovery Miles 19 920
Colorectal Cancer, An Issue of…
Kimmie Ng, Benjamin L Schlechter Hardcover R2,305 Discovery Miles 23 050

See more

Partners